These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4742680)

  • 21. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D
    Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
    [No Abstract]   [Full Text] [Related]  

  • 22. [A scheme of triple reserve drugs in the treatment of resistant forms of pulmonary tuberculosis].
    Rizzo A; Magalhães M; Moura N
    Hospital (Rio J); 1966 Sep; 70(3):767-83. PubMed ID: 5300283
    [No Abstract]   [Full Text] [Related]  

  • 23. Population screening for isoniazid acetylator phenotype.
    Seifart HI; Parkin DP; Botha FJ; Donald PR; Van Der Walt BJ
    Pharmacoepidemiol Drug Saf; 2001; 10(2):127-34. PubMed ID: 11499851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blood coagulation state in destructive pulmonary tuberculosis patients under different methods of chemotherapy].
    Sagalovich VIa; Beresneva RE; Ivanova VB
    Probl Tuberk; 1981 May; (5):30-4. PubMed ID: 7255385
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ofloxacin-cycloserine-protionamide-INH combination against treatment refractory lung tuberculosis].
    Mühlberger F; Nturanye F; Nasbimana J; Portaels F
    Pneumologie; 1995 Feb; 49(2):72-6. PubMed ID: 7724506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Estimation of plasma malonyl dialdehyde concentration in patients with pulmonary tuberculosis].
    Janiszewska-Drobińska B; Kowalski J; Błaszczyk J; Kedziora J; Kaczmarek P; Ciećwierz J
    Pol Merkur Lekarski; 2001 Oct; 11(64):310-3. PubMed ID: 11770308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Concentration of cycloserine in the blood of patients with pulmonary tuberculosis].
    Kagramanov AI; Kozulitsyna TI; Sennikov GN
    Antibiotiki; 1969 Jan; 14(1):89-92. PubMed ID: 4889841
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes in the blood coagulation in patients with pulmonary tuberculosis during treatment with preparations of the first order].
    Ivaniuta OM; Fomicheva NI; Chaban VM
    Vrach Delo; 1969 Aug; 8():38-9. PubMed ID: 5382482
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Concentration of several antituberculous agents in the blood and resected lungs in patients with tuberculosis].
    Kislitsyna NA; Kotova NI
    Probl Tuberk; 1977 Aug; (8):72-5. PubMed ID: 905278
    [No Abstract]   [Full Text] [Related]  

  • 31. The early bactericidal activity of amikacin in pulmonary tuberculosis.
    Donald PR; Sirgel FA; Venter A; Smit E; Parkin DP; Van de Wal BW; Mitchison DA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):533-8. PubMed ID: 11409580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of active isoniazid in the blood serum after intratracheal administration in patients with coniotuberculosis].
    Ryzhkova VV; Kasper GA; Bekembaev RM
    Probl Tuberk; 1973; 51(1):51-4. PubMed ID: 4727159
    [No Abstract]   [Full Text] [Related]  

  • 33. [Concentration of free isoniazid in blood and its urinary excretion in various methods of administration to children with pulmonary tuberculosis].
    Khrůleva TS
    Antibiotiki; 1970 Feb; 15(2):177-81. PubMed ID: 5309795
    [No Abstract]   [Full Text] [Related]  

  • 34. [Endocavernous treatment of caverns with atypical Mycobacteria].
    Neef W
    Z Erkr Atmungsorgane Folia Bronchol; 1970 Jun; 131(5):385-9. PubMed ID: 5210837
    [No Abstract]   [Full Text] [Related]  

  • 35. Measurement of plasma levels of isoniazid for dose adjustment in the hemodialysis patients.
    El Kabbaj D; Aatif M; Moussa LA; Khassouani CE; Oualim Z
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):666-7. PubMed ID: 19587514
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of basic tuberculostatic preparations of the 1st and 2d order in the bioelectric activity of the brain in patients with pulmonary tuberculosis].
    Shmelev NA; Shabalova LN
    Antibiotiki; 1969 Sep; 14(9):853-8. PubMed ID: 5361831
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana.
    Tappero JW; Bradford WZ; Agerton TB; Hopewell P; Reingold AL; Lockman S; Oyewo A; Talbot EA; Kenyon TA; Moeti TL; Moffat HJ; Peloquin CA
    Clin Infect Dis; 2005 Aug; 41(4):461-9. PubMed ID: 16028152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Leukergy in patients with pulmonary tuberculosis treated for the first time with antitubercular drugs].
    Przemyska B
    Gruzlica; 1967; 35(11):1169-74. PubMed ID: 6063620
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intrabronchial infusion of drugs in pulmonary tuberculosis].
    Ogii NV
    Vrach Delo; 1976 Sep; (9):11-4. PubMed ID: 982958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.